Clinical Trial Update: A Trial to Assess the Efficacy and Safety of TEV-53408 in Adults With Celiac Disease [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating the efficacy and safety of TEV-53408 in adults with celiac disease is currently not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Celiac Disease

Drugs mentioned

• TEV-53408

Snippet

Sponsor: Teva Branded Pharmaceutical Products R&D LLC | Conditions: Celiac Disease | Phase 2 | Status: ACTIVE_NOT_RECRUITING